Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials

Christopher E.M. Griffiths^*, Kristian Reich, Mark Lebwohl, Peter Van De Kerkhof, Carle Paul, Alan Menter, Gregory S. Cameron, Janelle Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel K. Braun, Olawale O. Osuntokun, Michael P. Heffernan, Brian J. Nickoloff, Kim Papp, Diamant Thaci